Telmisartan did not affect biomarkers of central nervous system inflammation or injury when used as an adjunct to ART for acute HIV infection.
In this case study presented at ACTRIMS 2020, researchers reported on data from a patient with Crohn disease and ankylosing spondylitis who developed autoimmune encephalitis while receiving infliximab.
A study of Chinese healthcare workers may foreshadow the mental health burden placed upon physicians, nurses, and other professionals as COVID-19 strains the medical system in the United States.
Recovery after multilevel lumbar interbody fusion is similar between patients who receive weekly teriparatide and bisphosphonate therapy.
According to a review published in The New England Journal of Medicine, evidence from preclinical studies and clinical trials on intermittent fasting reveals benefits for a number of health conditions, including obesity, diabetes mellitus, cardiovascular disease, cancers, and neurologic disorders.
The Food and Drug Administration (FDA) has granted Fast Track designation to LYS-SAF302 (Lysogene), an investigational gene therapy for the treatment of mucopolysaccharidosis Type IIIA (MPS IIIA).
Rates of suicide are significantly higher for individuals diagnosed with a neurological disorder versus the general population.
In a cohort of osteopathic medical students in the Midwestern United States, burnout was predicted by high stress, poor sleep quality, and excessive smartphone use.
4CMedB, a new multi-antigen vaccine designed to control group B meningococcal disease, had no effect on carriage of disease-causing meningococci in adolescents.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to PIC1-dPEG24 (ReAlta Life Sciences) for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates.